vx 497 has been researched along with etravirine in 1 studies
Studies (vx 497) | Trials (vx 497) | Recent Studies (post-2010) (vx 497) | Studies (etravirine) | Trials (etravirine) | Recent Studies (post-2010) (etravirine) |
---|---|---|---|---|---|
25 | 3 | 7 | 572 | 90 | 321 |
Protein | Taxonomy | vx 497 (IC50) | etravirine (IC50) |
---|---|---|---|
Chain A, Reverse transcriptase/ribonuclease H | HIV-1 M:B_HXB2R | 0.0021 | |
Chain B, p51 RT | HIV-1 M:B_HXB2R | 0.0021 | |
Chain A, Reverse transcriptase/ribonuclease H | HIV-1 M:B_HXB2R | 0.0021 | |
Chain B, p51 RT | HIV-1 M:B_HXB2R | 0.0021 | |
ATP-binding cassette sub-family C member 3 | Homo sapiens (human) | 5.1 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.025 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 7.6 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.019 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.032 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 0.017 | |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | 0.37 | |
Cruzipain | Trypanosoma cruzi | 4 | |
Multidrug resistance-associated protein 1 | Homo sapiens (human) | 8.5 | |
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.01 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.097 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.01 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.01 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.01 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.01 | |
Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 0.2711 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.01 | |
Canalicular multispecific organic anion transporter 1 | Homo sapiens (human) | 7.8 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.01 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 6 | |
Reverse transcriptase | Human immunodeficiency virus 1 | 0.0186 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
1 other study(ies) available for vx 497 and etravirine
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |